Permeation Studies and Histological Examination of Sheep Nasal Mucosa Following Administration of Different Nasal Formulations with or without Absorption Enhancers

REFERENCES

• Aikawa K., Matsumoto K., Mitsutake N., Uda H., Tanaka S., Shimamura H., Aramaki Y., Tsuchiya S. Drug release from pH-response polymer to nasal delivery. S. T. P. Pharm Sci. 2002; 12: 69–74
   Web of Science ®Google Scholar
• Akhgari A., Sadeghi F., Garekani H. A. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. Int. J. Pharm. 2006; 320: 137–142
   PubMed Web of Science ®Google Scholar
• Chien Y. W., Su S. E., Chang S. F. Nasal Systemic Drug Delivery, Vol. 39. Ed. Marcel Dekker, New York 1989
   Google Scholar
• Cui F., Qian F., Yin C. Preparation and characterization of mucoadhesive polymer-coated nanoparticles. Int. J. Pharm. 2006; 316: 154–161
   PubMed Web of Science ®Google Scholar
• Fang J. Y., Hwang T. L., Leu Y. L. Effect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels. Int. J. Pharm. 2003; 250: 313–325
   PubMed Web of Science ®Google Scholar
• Ferreira L. A. M., Seiller M., Grossiord J. L., Marty J. P., Wepierre J. Vehicle influence on in vitro release of glucose: w/o, w/o/w and o/w systems compared. J.Control. Release 1995; 33: 349–356
   Web of Science ®Google Scholar
• Gavini E., Hegge A. B., Rassu G., Sanna V., Testa C., Pirisino G., Karlsen J., Giunchedi P. Nasal administration of Carbamazepine using chitosan microspheres: In vitro/in vivo studies. Int. J. Pharm. 2006; 307: 9–15
   PubMed Web of Science ®Google Scholar
• Gizurarson S. The relevance of nasal physiology to the design of drug absorption studies. Adv. Drug Del. Rew. 1993; 11: 329–347
   Web of Science ®Google Scholar
• Huang Z. L., Kagoshima M., Kagawa E., Shimada H. Absorption of indomethacin from nasal cavity in rats. Acta Pharma. Sin. 1995; 16: 117–120
   Web of Science ®Google Scholar
• Illium L. Nasal drug delivery: New developments and strategies. DDT. 2002; 7: 1184–1189
   PubMed Web of Science ®Google Scholar
• Illum L., Fisher A. N., Jabbal-Gill I., Davis S. S. Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides. Int. J. Pharm. 2001; 222: 109–119
   PubMed Web of Science ®Google Scholar
• Kan P., Chen Z. B., Kung R. Y., Lee C. J., Chu I. M. Study on the formulation of O/W emulsion as carriers for lipophilic drugs. Colloids and Surfaces B Biointerfaces. 1999; 15: 117–125
   Web of Science ®Google Scholar
• Karasulu E., Karasulu H. Y., Ertan G., Kırılmaz L., Güneri T. Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release raes. E. J. Pharm. Sci. 2003; 19: 99–104
   PubMed Web of Science ®Google Scholar
• Karasulu H. Y., ™anal Z. E., Sözer S. Potent anti-inflammatory activity of intranasal indomethacin emulsion in rats. European Conference on Drug Delivery and Pharmaceutical Technology. 2004, (Sevilla-2004). 77
   Google Scholar
• Kissel T., Werner U. Nasal delivery of peptides: an in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium. J.Control. Release 1998; 53: 95–203
   Google Scholar
• Li Y., Jiang H. L., Zhu K. J., Liu J. H., Hao Y. L. Preparation characterization and nasal delivery of α -cobrotoxin-loaded poly(lactide-co-glycolide)/polyanhydride microspheres. J. Control. Release 2005; 108: 10–20
   PubMed Web of Science ®Google Scholar
• Longenecker J. P., Moses A. C., Flier J. S., Silver R. D., Carey M. C., Dubovi E. J. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep. J. Pharm. Sci. 1987; 76: 351–355
   PubMed Web of Science ®Google Scholar
• The Merck Index, 24th ed. Merck Research Laboratories Division of Merck and Co., Inc., Whitehouse Station, NJUSA 1996, Ed: Susan Budavari, USA
   Google Scholar
• Mitra R., Pezron I., Chu W. A., Mitra A. K. Lipid emulsions as vehicles for enhanced nasal delivery of insulin. Int. J. Pharm. 2000; 205: 127–134
   PubMed Web of Science ®Google Scholar
• Sinswat P., Tengamnuay P. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-β -cyclodextrins. Int. J. Pharm. 2003; 257: 15–22
   PubMed Web of Science ®Google Scholar
• Tas C., Ozkan C. K., Savaser A., Ozkan Y., Tasdemir U., Altunay H. Nasal absorption of metoclopramide from different Carbopop 981 Based Formulations: In vitro, ex vivo and in vivo evaluation. Eur. J. Pharm. Biopharm. 2006; 64: 246–254
   PubMed Web of Science ®Google Scholar
• Tirucherai G. S., Pezron I., Mitra A. K. Novel approaches to nasal delivery of peptides and proteins. STP Pharm. Sci. 2002; 12: 3–12
   Google Scholar
• Todo H., Okamoto H., Iida K., Danjo K. Improvement of stability and absorbability of dry insulin powder for inhalation by powder-combination technique. Int. J. Pharm. 2004; 271: 41–52
   PubMedGoogle Scholar
• Uzunkaya G., Bergiadi N. In vitro drug liberation and kinetics of sustained release indomethacin suppository. Il Farmaco 2003; 58: 509–512
   PubMedGoogle Scholar
• Vermehren C., Hansen H. S. Shape changes in the erythrocyte membrane induced by the absorption enhancer didecanoylphosphatidylcholine. Int. J. Pharm. 1998; 174: 1–8
   Google Scholar
• Wang J., Lu W.-L., Liang G-W., Wu K-C., Zhang C-G., Zhang X., Wang J-C., Zhang H., Wang X-O., Zhang O. Pharmacokinetics, toxicity of nasal cilia and immunomodulating effects in Sprague–Dawley rats following intranasal delivery of thymopentin with or without absorption enhancers. Peptides 2006; 27: 826–835
   PubMed Web of Science ®Google Scholar
• Welin-Berner K., Neelissen J. A. M., Bergenstahl B. The effect of reological behaviour of a topical anasthetic formulation on the release and permeation rates of the active compound. Eur. J. Pharm. Sci. 2001; 13: 309–318
   PubMedGoogle Scholar
• Wingertzahn M. A., Sato H., Nave R., Nonaka T., Mochizuki T., Takahama S., Kondo S. Comparison of nasal tissue concentrations in rabbits following administration of hypotonic and isotonic ciclesonide suspensions. J.Allergy. Clin. Immunol. 2005; 115: 126
   Google Scholar
• Yetkin G., Celebi N., Ozogul C., Demiryurek A. T. Enhancement of nasal absorption of salmon calcitonin in rabbits using absorption enhancer. STP Pharm. Sci. 2001; 11: 187–191
   Google Scholar
• Yu S., Zhao Y., Wu F., Zhang X., Lü W., Zhang H., Zhang O. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies. Int. J. Pharm. 2004; 281: 11–23
   PubMed Web of Science ®Google Scholar